We sought, therefore, to study the predictive values of memory CD8+ T, memory CD4+ T, naïve CD8+ T, and naïve CD4+ T for tumor response to SBRT in patients with NSCLC lung metastases. The gene discussed is CD4; the disease is neoplasm.